Project Detail:
Full
commercial due diligence for a leading independent imaging platform
Functional Areas:
Commercial
/ Strategy / Market Assessment
Company Type:
Pan-European
Platform
Therapy Area:
Diagnostics
/ Medical Imaging
Problem Statement
A
private equity investor sought to build conviction on an acquisition of a
pan-European diagnostic imaging platform, requiring a clear view on market
attractiveness, competitive positioning, and the sustainability of growth
Our Approach
We took an outside-in approach to pressure-test the investment case
- Assessed market attractiveness across key European
geographies, validating demand driven by aging populations, rising
diagnostic intensity, and outsourcing trends
- Benchmarked the platform against leading competitors on
clinical quality, pricing, network scale, and technology capabilities
- Analyzed modality-level economics (MRI, CT, PET-CT),
including utilization, reimbursement, pricing, and capital intensity
- Evaluated network strength, including geographic
footprint, capacity utilization, and referral dynamics
- Identified key value drivers and risks, and tested the
robustness of the growth narrative
Outcome
- Validated a resilient, non-discretionary demand profile
underpinned by structural healthcare trends
- Confirmed strong competitive positioning with clear
differentiation versus fragmented independent providers
- Identified actionable value creation levers, including
network expansion and bolt-on acquisitions
- Enabled a high-conviction investment thesis, positioning
the platform as a scalable, asset-backed growth opportunity